Efficacy News and Research

RSS
Sulindac drug derivative effective in preventing colon cancer: Research

Sulindac drug derivative effective in preventing colon cancer: Research

Isotechnika announces CONFIRM1 clinical trial results at TCT 2010 Symposium

Isotechnika announces CONFIRM1 clinical trial results at TCT 2010 Symposium

Shoulder pain costs American health system $7 billion

Shoulder pain costs American health system $7 billion

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

GSA urges treatment of sepsis as a medical emergency

GSA urges treatment of sepsis as a medical emergency

Global phase IV study confirms efficacy of erlotinib in treatment of non-small cell lung cancer

Global phase IV study confirms efficacy of erlotinib in treatment of non-small cell lung cancer

FDA takes action against unapproved single-ingredient oral colchicine

FDA takes action against unapproved single-ingredient oral colchicine

DMC recommends continuation of enrollment in Celsion's Phase III ThermoDox HEAT study for primary liver cancer

DMC recommends continuation of enrollment in Celsion's Phase III ThermoDox HEAT study for primary liver cancer

Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency

Study demonstrates rufinamide therapy is effective in reducing partial seizure frequency

NIH awards Polymedix $986,000 to develop defensin mimetic antimicrobial compounds for oral candidiasis

NIH awards Polymedix $986,000 to develop defensin mimetic antimicrobial compounds for oral candidiasis

Erchonia launches Zerona body-contouring laser in South East Asia

Erchonia launches Zerona body-contouring laser in South East Asia

Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

Repligen Corporation completes patient enrollment in RG2417 Phase 2b clinical trial

sanofi-aventis announces top-line results from lixisenatide Phase III GETGOAL-L-ASIA trial for Type-2 Diabetes

sanofi-aventis announces top-line results from lixisenatide Phase III GETGOAL-L-ASIA trial for Type-2 Diabetes

AVEO regains global rights for development, commercialization of AV-299 anti-HGF antibody candidate

AVEO regains global rights for development, commercialization of AV-299 anti-HGF antibody candidate

FDA grants Type B meeting to review Phase III pivotal efficacy protocols for Androxal

FDA grants Type B meeting to review Phase III pivotal efficacy protocols for Androxal

Best P.A.D. Research Awards honor investigators for research on peripheral arterial disease

Best P.A.D. Research Awards honor investigators for research on peripheral arterial disease

AccuPSA test for detecting prostate cancer recurrence

AccuPSA test for detecting prostate cancer recurrence

Mount Sinai receives contract to develop nanotechnology tools for diagnosing diseases

Mount Sinai receives contract to develop nanotechnology tools for diagnosing diseases

Zyclara 3.75% more effective than cryotherapy alone in treatment of Actinic Keratoses: Study

Zyclara 3.75% more effective than cryotherapy alone in treatment of Actinic Keratoses: Study

Santarus, Cosmo announce positive results from budesonide MMX Phase III study in ulcerative colitis

Santarus, Cosmo announce positive results from budesonide MMX Phase III study in ulcerative colitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.